2BB score and signals
Rani Therapeutics Holdings, Inc.’s current 2BB score is 27 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 62 | Strong |
| Quality | 80 | Very Strong |
| Risk | 49 | Moderate |
Company facts
| Headquarters | San Jose, California, United States |
| Founded | 2012 |
| Employees | 70 |
| 52-week range | $0.39 – $3.87 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-05 | — | -0.0485 | — | $1.31M |
| 2026-08-06 | — | -0.051 | — | $943,500.00 |
| 2026-05-15 | -0.04 | -0.0459 | $1.71M | $510,000.00 |
| 2026-03-26 | -0.07 | -0.068 | $1.46M | $5.10M |
2BBBullish & Bearish